A Clinical Trial Evaluating Efficacy and Safety of MC2-01 Cream
Status:
Completed
Trial end date:
2018-06-08
Target enrollment:
Participant gender:
Summary
This trial is a randomized, investigator-blind, multicentre, vehicle- and
comparator-controlled, parallel-group trial with the purpose of evaluating efficacy, safety
and convenience of the MC2-01 cream.
Phase:
Phase 3
Details
Lead Sponsor:
Drug Delivery Solutions Ltd. (part of MC2 Therapeutics) MC2 Therapeutics